Fig. 4From: Prevalence of G6PD deficiency and diagnostic accuracy of a G6PD point-of-care test among a population at risk of malaria in MyanmarReceiver operator characteristic curve analysis and CareStart™ G6PD biosensor and SSA at 30% (Fig. 4A), 70% (Fig. 4B), and 80% (Fig. 4C) SSA-G6PD activity cut-offBack to article page